IBT
HRMY icon

International Biotechnology Trust’s Harmony Biosciences HRMY Stock Holding History

International Biotechnology Trust’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$10.3M Sell
314,500
-256,000
-45% -$8.89M 3.47% 9
2023
Q2 		$20.1M Hold
570,500
– – 6.11% 3
2023
Q1 		$18.6M Buy
570,500
+306,000
+116% +$13.9M 5.2% 4
2022
Q4 		$14.6M Hold
264,500
– – 4.5% 5
2022
Q3 		$11.7M Buy
264,500
+253,706
+2,350% +$12.4M 3.76% 7
2022
Q2 		$222K Sell
10,794
-194,680
-95% -$8.76M 2.31% 17
2022
Q1 		$20.5M Sell
205,474
-30,526
-13% -$1.25M 4.63% 5
2021
Q4 		$10.1M Hold
236,000
– – 2.24% 17
2021
Q3 		$9.02M Buy
236,000
+70,000
+42% +$2.25M 2.18% 17
2021
Q2 		$4.69M Buy
+166,000
New +$4.98M 1.24% 22

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

International Biotechnology Trust's HRMY Position: Q3 2023 in Review

International Biotechnology Trust reduced its Harmony Biosciences (HRMY) stake by 45% in Q3 2023, selling an estimated $8.89M and leaving 314,500 shares worth $10.3M. The position accounts for 3.47% of the portfolio, ranked #9.

International Biotechnology Trust first reported a position in HRMY in Q2 2021 and has held it in 10 quarters since. The position peaked at $20.5M in Q1 2022. 204 funds tracked by Wall St. Rank hold HRMY as of Q3 2023.

  • International Biotechnology Trust held 314,500 shares of Harmony Biosciences worth $10.3M as of Q3 2023.
  • International Biotechnology Trust sold 256,000 Harmony Biosciences shares in Q3 2023, an estimated $8.89M.
  • Harmony Biosciences made up 3.47% of International Biotechnology Trust's portfolio in Q3 2023, its #9 holding.
  • International Biotechnology Trust first reported a position in Harmony Biosciences in Q2 2021 and has held it in 10 quarters since.
  • International Biotechnology Trust's Harmony Biosciences position peaked at $20.5M in Q1 2022.
  • 204 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.